🇺🇸 FDA
Pipeline program

Fentanyl Buccal Tablet

C25608/3056/BP/US

Phase 3 small_molecule completed

Quick answer

Fentanyl Buccal Tablet for Chronic Pain is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Chronic Pain
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials